Katelyn Uhlemann
Physician Assistant · Denver, CONPI 1144628223
Payments from drug & device makers
Across 201 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$539
- Lilly USA, LLC$512
- AbbVie$290
- Novo Nordisk$263
- Pfizer$203
- Astellas Pharma US Inc$163
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,49798%
- Education$852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 28 | $539 |
| Lilly USA, LLC | 34 | $512 |
| AbbVie | 16 | $290 |
| Novo Nordisk | 14 | $263 |
| Pfizer | 12 | $203 |
| Astellas Pharma US Inc | 5 | $163 |
| Amneal Pharmaceuticals LLC | 8 | $148 |
| Exact Sciences | 6 | $145 |
| Boehringer Ingelheim | 7 | $145 |
| Johnson & Johnson | 8 | $142 |
| Amgen | 8 | $137 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $135 |
| Biohaven Pharmaceuticals, Inc. | 4 | $66 |
| GSK | 4 | $61 |
| Nestle Healthcare Nutrition Inc. | 3 | $59 |
| Clarus Therapeutics Inc. | 4 | $58 |
| Amarin Pharma, Inc. | 3 | $56 |
| Merck | 4 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $49 |
| Novartis | 3 | $43 |
| Acadia Pharmaceuticals Inc | 2 | $34 |
| Eisai Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Dynavax Technologies Corporation | 2 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Corium, LLC | 3 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Vertex | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Abbott | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
How this compares
$3,582 in reported general payments places this provider in the 90th percentile of 2,849 physician assistant providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 19 | $22,114 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $11,813 |
| FarxigaDapagliflozin Propanediol | 11 | $5,991 |
| Allopurinol | 21 | $1,523 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $1,122 |
| SynthroidLevothyroxine Sodium | 18 | $945 |
| Triazolam | 12 | $702 |
| Bupropion XlBupropion Hcl | 31 | $673 |
| Levothyroxine Sodium | 79 | $606 |
| Atorvastatin Calcium | 82 | $601 |
| Rosuvastatin Calcium | 83 | $569 |
| ValacyclovirValacyclovir Hcl | 11 | $482 |
| Duloxetine Hcl | 19 | $443 |
| Omeprazole | 34 | $414 |
| Olmesartan Medoxomil | 26 | $351 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $512 | $22,11419 claims |
| GSKTrelegy Ellipta | $61 | $11,81318 claims |
| AstraZenecaFarxiga | $539 | $5,99111 claims |
| AbbVieSynthroid | $290 | $94518 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $148 | $60679 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $20 | $30411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Denver
- Kristen LervikDenver$131K
- Emily FrischDenver$79K
- Andrew GardnerDenver$68K
- Ethan MytingerDenver$19K
- Karen WilderDenver$16K
- Mariam MikeladzeDenver$12K
- Laura MurrayDenver$10K
- Corbin RogersDenver$10K
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.